Macquarie Health Services

What Macquarie Health Services does

Macquarie Health Corporation is an Australian privately held, founder-controlled healthcare group established in Sydney in 1973 by Dr Thomas Wenkart. It operates 12 multidisciplinary private hospitals across New South Wales and Victoria delivering surgical, rehabilitation, and mental health and substance abuse services, supported by approximately 1,500 staff, nurses, and doctors and 21 state-of-the-art operating theatres. The group also holds medical and commercial real estate and runs dedicated rapid-access programs in cardiac rehabilitation (Heart Wellness) and weight loss interventions.

Beyond hospital services, Macquarie Health operates three distinct technology and product businesses. Macquarie Medical Systems manufactures and distributes biomedical monitoring equipment, patient monitoring devices, dermatoscopes, and disposable surgical consumables across Australia and New Zealand. Derma Medical Systems, headquartered in Vienna with a US office in San Diego, manufactures and globally distributes the MoleMax digital skin imaging system (launched in 1997 as the first integrated digital microscopy and macro imaging platform in the world) and the DermaFOTO hand-held imaging device, deployed at over 3,000 sites worldwide. Pen CS provides population health analytics software used by Primary Health Networks, the Australian Digital Health Agency, NSW Ministry of Health, Aboriginal Community Controlled Health Organisations, and the AIHW, aggregating over 200 million de-identified patient records per annum from 4,600 general practices and 7,900 doctors. Machealth eSolutions adds digital health products including YourDiagnosis and YourHealthRecord, and MacRehab delivers specialised rehabilitation services.

The company monetises through a mix of private hospital service fees billed to patients and insurers (subscription-like recurring revenue), B2B hardware sales of medical devices globally, and software/data subscriptions or licensing to government and institutional buyers in primary care. Go-to-market is sales-led and referral-driven, relying on Visiting Medical Officer accreditation, specialist referral networks, direct hospital enquiry channels, and an international dealer/distributor network for devices. The Wenkart Foundation (est. 1976) and the Health Care Research Institute handle philanthropic and research activities separately from commercial operations, including endowment of the Wenkart Chair of the Endothelium at the University of Sydney's Centenary Institute.

Name

Macquarie Health Services

Legal name

Macquarie Health Corporation

Website

https://machealth.com.au

Company type

Private

Founded year

1973

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Macquarie Health Corporation is a privately held Australian healthcare group operating 12 private hospitals, medical device businesses (Macquarie Medical Systems, Derma Medical Systems/MoleMax), and the Pen CS population health analytics platform, serving patients, clinicians, and government health bodies across Australia with global device distribution.

Ownership category

akta.pro rank

Product category

Private Healthcare Services

NAICS

General Medical and Surgical Hospitals (622110), General Medical and Surgical Hospitals (6221), Offices of Mental Health Practitioners (except Physicians) (62133)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Hospital-Owned Physician Networks & Medical Groups (HLAFAAAL)

akta.pro secondary industries

Health Data, Vital Statistics & Population Health Informatics (BPAIAJAM), De-identification, Tokenization & Privacy-Preserving Data Platforms (HLACAIAK), Care Management & Coordination Platforms (case/disease management workflows) (HLACAHAD)

Keywords

• Private hospital services
• Medical device manufacturing
• Population health analytics
• Digital skin imaging
• Rehabilitation programs

Headquarters

HQ city

Sydney

HQ country

Australia

HQ region

Oceania

Offices14 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Private Hospital Services: Revenue generated from surgical, rehabilitation, and mental health inpatient and day programs across 12 private hospitals on Australia's Eastern Seaboard. Services include orthopaedic, cardiac, pulmonary, neurological rehabilitation, bariatric, pain management, and mental health/substance abuse programs.
2. Medical Device Sales and Distribution: Macquarie Medical Systems and Derma Medical Systems generate revenue from the manufacture and sale of biomedical monitoring equipment, dermatoscopes, patient monitoring devices, disposable surgical consumables, and the MoleMax digital skin imaging range. Products are sold in Australia, New Zealand, Europe, Asia, Africa and North America.
3. eHealth Informatics and Data Solutions: Pen CS generates revenue from health analytics software sold to Primary Healthcare Networks (PHNs), ACCHOs, Aboriginal Medical Services, Australian Digital Health Agency, Ministry of Health NSW, research institutes, and private, government and not-for-profit organisations. Monthly audience reach of 18 million patients, 7,900 doctors, and 4,600 general practices.
4. Medical and Commercial Real Estate: Macquarie Health holds and manages medical and commercial real estate assets as part of its portfolio.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

Core offering

Macquarie Health Corporation operates a diversified healthcare group with three core lines: (1) 12 multidisciplinary private hospitals providing surgical, rehabilitation, and mental health services across Australia's Eastern Seaboard; (2) medical device manufacturing and distribution (biomedical monitoring equipment, dermatoscopes, and the world-first MoleMax digital skin imaging system) through Macquarie Medical Systems and Derma Medical Systems; (3) eHealth informatics and population health analytics through Pen CS, which aggregates over 200 million de-identified patient records annually across 4,600+ general practices for Primary Health Networks and government health bodies.

Product overview

Macquarie Health Services operates as a diversified healthcare company with a platform-plus-subsidiaries architecture. The core business encompasses 12 private hospitals providing surgical, rehabilitation, and mental health services across Australia. Under the hospital division, it offers specialized surgical hospitals with 21 operating theatres, rehabilitation hospitals with multidisciplinary allied health programs, and mental health/substance abuse clinics. The company also operates healthcare technology subsidiaries including Macquarie Medical Systems (biomedical devices), Derma Medical Systems (digital skin imaging), Pen CS (population health analytics software), and eHealth solutions (YourDiagnosis, YourHealthRecord). MacRehab provides specialized rehabilitation services. The portfolio connects hospital care delivery with health informatics and medical device manufacturing.

Differentiator

Problem solved

Functional benefit

Brands

• Macquarie Medical Systems: Biomedical division manufacturing and distributing medical monitoring equipment and devices
• MacRehab
• Pen CS
• Derma Medical Systems
• Machealth eHealth solutions

Products and services

• Macquarie Health Hospitals Network of 12 owned and operated multidisciplinary care private hospitals across NSW and Victoria (Eastern Suburbs, Inner West, Northern Beaches, Greater Western Sydney, South/South West Sydney, Melbourne Eastern) offering surgical, rehabilitation, and mental health services delivered by approximately 1,500 staff, nurses, and doctors.
• Surgical Hospitals Surgical procedures delivered across 21 state-of-the-art operating theatres spanning the surgical hospital network; specialisations include general, ophthalmic, plastic/cosmetic, bariatric, endoscopy, urology, oral/faciomaxillary, gynaecology, paediatric, ENT, and colorectal surgeries.
• Rehabilitation Hospitals
• Mental Health Hospitals & Clinics
• Heart Wellness
• Weight Loss Interventions
• Macquarie Medical Systems
• Derma Medical Systems (MoleMax Digital Skin Imaging)
• Pen CS eHealth Data Solutions
• YourDiagnosis
• YourHealthRecord
• MacRehab

Quantifiable outcome

• Pen CS platform processes over 200 million de-identified patient records per annum across Australia's primary care network
• +4 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• University of Sydney and Centenary InstitutecoreStrategic or Co-development Partner · 1 January 2012The Wenkart Foundation, established by Macquarie Health founder Dr Thomas Wenkart, endowed the Wenkart Chair of Endothelium Medicine at the University of Sydney's Centenary Institute in 2012 with a $4 million donation in the presence of NSW Governor Dr Marie Bashir. This world-first academic chair in endothelium medicine represents a deep research partnership and is central to the Wenkart Foundation's health sciences mission.
• Health Care Research Institute (HCRI)coreStrategic or Co-development Partner · 1 January 1976The Health Care Research Institute (HCRI) was founded by Dr Thomas Wenkart in 1976 as part of the not-for-profit arm of Macquarie Health's activities. HCRI awards grants in health and medical sciences through a panel of senior individuals drawn from healthcare delivery, medical research, law, finance, IT and business development, representing a broad community spectrum.
• Pen CScoreStrategic or Co-development PartnerPen CS is Australia's leading provider of health analytics software for national population health analysis and reporting in primary care. Macquarie Health associates with Pen CS as a strategic partner providing eHealth informatics and data solutions. Pen CS operates on the Macquarie Health platform, collecting over 200 million de-identified patient records per annum and working with Primary Health Networks, Indigenous health bodies, Australian Digital Health Agency, and Ministry of Health NSW.
• Cosmetic EvolutionminorStrategic or Co-development PartnerMacquarie Health Corporation is associated with Cosmetic Evolution, a provider of total body cosmetic surgery services. This is a referral and collaborative relationship within the specialist healthcare network.

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Ramsay Health Care: Australia’s largest private hospital operator with 72+ hospitals globally, including major NSW and Victorian presence. Directly comparable as a multi-site private acute, surgical, rehabilitation, and mental health provider on the same Eastern Seaboard markets as Macquarie Health.
• Healthscope: Major Australian private hospital group (now owned by Brookfield) operating surgical and rehabilitation hospitals across NSW, Victoria, and other states. Comparable as a multi-site private hospital operator with overlapping service lines and geographies.
• Epworth HealthCare: Victoria’s largest not-for-profit private hospital group with strong rehabilitation, surgical, and mental health programs. Directly competes with Macquarie’s Melbourne Eastern, Essendon, and Malvern facilities in the Victorian private hospital market.
• St John of God Health Care: Catholic not-for-profit private hospital operator across Australia with significant surgical, rehabilitation, and mental health services. Comparable as a multi-site private provider with overlapping specialty programs and referral-driven GTM model.
• Calvary Health Care: National not-for-profit private hospital and aged care group with strong NSW and Victorian presence. Comparable as a multi-site operator of acute, rehabilitation, and mental health services competing for the same specialist referral networks.

Broad incumbents

• Healius: Diversified Australian healthcare operator historically anchored in primary care (formerly Primary Health Care). Comparable as a multi-vertical Australian healthcare platform spanning diagnostics, day hospitals, and primary care services.
• Sonic Healthcare: Global diagnostics and healthcare operator with strong Australian footprint. Relevant adjacency given Macquarie’s former ownership of Macquarie Pathology Services and shared history of vertically integrated Australian healthcare platforms.
• Telstra Health: Health technology arm of Telstra providing population health, analytics, and digital health solutions to PHNs and government. Directly comparable to Pen CS in the Australian primary care analytics market.

Emerging players

• Beamtree Holdings: Australian health analytics company providing decision support, clinical coding, and benchmarking tools to hospitals and PHNs. Comparable as a competing Australian health data analytics vendor targeting similar PHN and hospital customers.

Regional players

• Icon Group: Australian-headquartered cancer care provider with day hospitals and oncology services across the Eastern Seaboard. Comparable as a specialty hospital operator with strong NSW and Victorian presence and similar referral-driven patient acquisition model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/machealth
• LinkedInlinkedin.com/company/macquarie-health-corporation

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries16 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Macquarie Health Services